Trial Profile
A retrospective cohort study comparing gender specific effectiveness of rivaroxaban, dabigatran and warfarin for stroke prevention in elderly patients with newly diagnosed atrial fibrillation
Status:
Completed
Phase of Trial:
Phase IV
Latest Information Update: 03 Jul 2017
Price :
$35
*
At a glance
- Drugs Dabigatran etexilate (Primary) ; Rivaroxaban (Primary) ; Warfarin
- Indications Stroke
- Focus Therapeutic Use
- 03 Jul 2017 New trial record